Spectranetics Patents – Insights & Stats

Spectranetics has a total of 579 patents globally, out of which 388 have been granted. Of these 579 patents, more than 58% patents are active. The United States of America is where Spectranetics has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Spectranetics.

Spectranetics is subpart of Philips was founded in the year 1984. The Company develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Company’s CVX-300 excimer laser system is used in applications such as coronary angioplasty and the removal of pacemaker leads. Spectranetics is also developing other applications in restenosis stents and peripheral vascular applications.

Do read about some of the most popular patents of Spectranetics which have been covered by us in this article and also you can find Spectranetics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Spectranetics patent portfolio.

How many patents does Spectranetics have?

Spectranetics has a total of 579 patents globally. These patents belong to 129 unique patent families. Out of 579 patents, 338 patents are active.

How Many Patents did Spectranetics File Every Year?

Spectranetics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSpectranetics Applications FiledSpectranetics Patents Granted
202317
2022113
2021530
2020640
20191244
20181849
20174934
20164731
20159134
20145119
20136612
20121210
20112621

How many Spectranetics patents are Alive/Dead?

Worldwide Patents

Spectranetics Patents Portfolio

How Many Patents did Spectranetics File in Different Countries?

Spectranetics Worldwide Patents

Countries in which Spectranetics Filed Patents

CountryPatents
United States Of America287
Europe70
Germany43
Japan35
Austria35
China9
Hong Kong (S.A.R.)9
Australia7
United Kingdom5
Canada5
Spain4
Korea (South)4
New Zealand4
Russia3
Brazil2
Italy2
India1

Where are Research Centers of Spectranetics Patents Located?

Research Centers of Spectranetics Patents

10 Best Spectranetics Patents

US8097012B2 is the most popular patent in the Spectranetics portfolio. It has received 278 citations so far from companies like Ethicon Endo-Surgery Inc, and Cilag Gmbh International.

Below is the list of 10 most cited patents of Spectranetics:

Publication NumberCitation Count
US8097012B2278
US7303533B2179
US9668765B2167
US20050177130A1152
US6852109B2144
US20090105687A1141
US7686824B2140
US6970732B2126
US6772014B2122
US6752800B1122

How many inventions of other companies were rejected due to Spectranetics patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Spectranetics invention. They couldn’t because Spectranetics had protected those before them.

Examiners at the USPTO referred 81 Spectranetics patents in 471 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Spectranetics patent portfolio are Boston Scientific, Medtronic and Cook Medical Technologies.

List of the Companies whose Patents were rejected citing Spectranetics –

CompanyNumber of Patent Applications that faced Rejection Citing Spectranetics PatentsNumber of Rejections (102 & 103)
Boston Scientific2050
Medtronic1223
Cook Medical Technologies1017
Teleflex Life Sciences1041
Bolt Medical Inc814
Covidien715
Eximo Medical Ltd59
Xablecath Inc45
Abbott48
Biotronik Ag34

Count of 102 and 103 Type Rejections based on Spectranetics Patents

Top Spectranetics Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US10842567B210
US9028520B29
US7931663B28
US7691119B27
US20050177130A17
US9066742B27
US8956376B26
US8998936B25
US8414568B25
US7686824B25
US9320530B25
US6951554B25
US9375328B25
US8080026B25
US9814862B25

What Percentage of Spectranetics US Patent Applications were Granted?

Spectranetics (Excluding its subsidiaries) has filed 311 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 266 have been granted leading to a grant rate of 89.8%.

Below are the key stats of Spectranetics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Spectranetics?

Law FirmTotal ApplicationsSuccess Rate
Philips Intellectual Property & Standards23493.86%
Kilpatrick Townsend & Stockton Llp2582.61%
Faegre Baker Daniels Llp1566.67%
Pillsbury Winthrop Shaw Pittman885.71%
Fishman Stewart Pllc660.00%
Dan Rottenberg50%
Cushman Darby & Cushman333.33%
Flehr Hohbach Test2100.00%
Armstrong Teasdale Schlafly & Davis1100.00%
Carter Deluca & Farrell Llp10.00%

What are Spectranetics key innovation segments?

What Technologies are Covered by Spectranetics?

The chart below distributes patents filed by Spectranetics in different countries on the basis of the technology protected in patents. It also represents the markets where Spectranetics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Spectranetics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Spectranetics?

Related Articles

Gripple Patents – Insights & Stats (Updated 2024)

Gripple has a total of 2125 patents globally, out of which 1264 have been granted. Of these 2125 patents, more than 61% patents are active. United Kingdom is where Gripple has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, United Kingdom seems

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.